共 50 条
- [41] A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteers CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1997 - 2009
- [43] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers Clinical and Experimental Nephrology, 2017, 21 : 407 - 416
- [44] Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (02):
- [46] Phase 1 First-in-Human, Single- and Multiple-Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (08): : 1025 - 1034
- [48] Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers BMC PHARMACOLOGY & TOXICOLOGY, 2017, 18
- [49] Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers BMC Pharmacology and Toxicology, 18